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OBJECTIVES The purpose of this study was to characterize left ventricular (LV) mechanics during acute
rheumatic fever (ARF) and to define factors influencing remodeling after the acute event.
BACKGROUND Acute rheumatic fever is associated with varying degrees of valvulitis and myocarditis, but the
impact of these factors on LV mechanics is poorly defined.
METHODS Echocardiograms and clinical data were reviewed in 55 patients aged 11.2 6 2.6 years during
ARF. Valve regurgitation was absent or mild in 33 (group I) and moderate or severe in 22
(group II). Forty-two children (75%) underwent a further examination after ARF.
RESULTS Group I patients demonstrated a mildly elevated LV size during ARF and had normal indexes
at follow-up. Group II patients demonstrated a markedly elevated LV size (end-diastolic
dimension z-score 3.6 6 1.8, p , 0.01 compared with the normal population) and decreased
shortening fraction (z-score 20.8 6 1.4, p , 0.05). The stress-velocity index, a z-score
describing the velocity of shortening-afterload relationship, was normal in group II patients
with mitral regurgitation (20.2 6 1.2, p 5 NS) but was depressed in those with aortic
regurgitation or both (21.4 6 1.4, p , 0.01). At follow-up the stress-velocity index remained
depressed (21.2 6 1.0, p , 0.01) and had deteriorated in those treated nonsurgically
compared with those treated surgically (interval change nonsurgical 20.7 6 1.2 vs. surgical
1.3 6 1.3, p 5 0.005).
CONCLUSIONS The evolution of contractile dysfunction during and after ARF is dependent on the degree
and type of valve regurgitation and may be influenced by surgical intervention. These findings
suggest that mechanical factors are the most important contributors to myocardial damage
during and after ARF. (J Am Coll Cardiol 2001;37:201–7) © 2001 by the American College
of Cardiology
Acute rheumatic fever (ARF) is a systemic inflammatory
illness characterized by varying degrees of synovitis, valvu-
litis, myocarditis and pericarditis. It is endemic in develop-
ing countries (1) and occurs in developed countries
especially among socially disadvantaged indigenous and
migrant communities (1–4). Chronic rheumatic heart dis-
ease with progressive left ventricular (LV) dilatation and
dysfunction is the most common form of acquired heart
disease and a leading cause of premature death in children
and young adults in the developing world (5). A number of
factors may contribute to myocardial damage in rheumatic
heart disease, including acute or chronic ventricular volume
overload and primary rheumatic myocardial involvement.
During ARF, changes in LV size are closely related to the
degree of valve regurgitation (6). Left ventricular function is
normal in the majority of patients, but, when cardiac
decompensation is seen, it is almost always accompanied by
severe mitral regurgitation (MR) or aortic regurgitation
(AR) (6,7). Although these observations suggest that im-
portant myocardial involvement is unusual in the absence of
significant valve regurgitation, the relative roles of abnormal
ventricular loading conditions and myocardial contractile
dysfunction have not been fully explored.
Information regarding myocardial contractile function dur-
ing and after rheumatic fever is needed to better define the
pathophysiology of the disease. Furthermore, an understanding
of patterns of recovery of ventricular geometry and the
progress of those with myocardial contractile dysfunction
are of considerable importance for this patient group where
ventricular dysfunction is a significant late complication.
METHODS
Patient population. Fifty-five patients who underwent
cardiology review at our institution between April 1994 and
May 1997 met the modified Jones criteria for the diagnosis
of ARF (8) and had satisfactory two-dimensional and
M-mode echocardiographic recordings available for analy-
sis. These 55 patients had echocardiograms at a median of
4 days (range 0 to 60 days) after initial hospitalization for
ARF. All had evidence of continuing rheumatic activity
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including elevated acute phase reactants. Mean age at the
time of ARF was 11.2 6 2.6 years (range 4 to 17 years), and
38 (69%) were male. A previous episode of ARF was known
or suspected in six patients (11%), two of whom had known
rheumatic valve disease (mild MR) before this presentation.
Thirty-three of the 55 (60%) had either no valve regurgi-
tation (n 5 8) or mild regurgitation (group I), while 22
(40%) had moderate or severe regurgitation (group II). All
patients were treated with penicillin for 10 days at the time
of initial presentation and then received intramuscular
benzathine penicillin every 28 days. Aspirin or acetamino-
phen was used for symptomatic relief of arthralgia or
arthritis. In addition, nine patients received intravenous
immunoglobulin during the acute phase of the illness as part
of a clinical trial. None received corticosteroids. At the time
of the initial study four children were treated with a diuretic
and one with digoxin. None were receiving a vasodilator.
Surgical intervention was undertaken in six group II
patients shortly after the initial examination because of
persistent congestive heart failure. Surgical procedures in-
cluded aortic valve replacement in three, mitral valve re-
placement in one, mitral valve repair in one and replacement
of both the aortic and mitral valves in one. Follow-up
examinations were undertaken in 22 of 33 group I patients
(67%) and 19 of 22 group II patients (86%) at a median of
12 months (range 5 to 40 months) after the initial study. At
the time of the follow-up examination none had clinical or
laboratory evidence of ongoing or recurrent rheumatic fever,
and all were receiving intramuscular penicillin every 28 days.
Four patients in group II were receiving a vasodilator; two
were receiving a diuretic, and one was receiving digoxin.
Normal subjects. Echocardiographic studies were also un-
dertaken in 84 normal subjects aged 14.0 6 5.5 years (range
5 to 23, median 12 years). None had a history of rheumatic
fever or other cardiovascular disease, and all had a normal
two-dimensional, M-mode and Doppler echocardiographic
examination.
Data collection. In addition to echocardiographic data, the
following parameters were collected: date of initial hospi-
talization, duration of symptoms, previous episodes of ARF,
medication history and erythrocyte sedimentation rate.
Echocardiographic technique. Complete two-dimensional
and Doppler examinations were recorded on super VHS
videotape using commercially available echocardiographic
equipment (Hewlett-Packard Sonos 1500 Cardiac Imager).
The end-systolic and end-diastolic long axes of the LV
cavity were measured in the apical four-chamber view and
averaged over three cardiac cycles. High speed (100 mm/s)
hard copy two-dimensional directed M-mode recordings of
the LV short axis over three to six cardiac cycles were
obtained simultaneously with an electrocardiogram, phono-
cardiogram and indirect carotid artery pulse tracing. Systolic
and diastolic blood pressures were obtained as the average of
three automated cuff recordings using a Dinamap 845 Vital
Signs monitor (Criticon, Inc.).
Assessment of valve regurgitation. Regurgitation was
graded as none (including physiological or nonholodiastolic
MR), mild, moderate and severe using standard criteria.
Mitral regurgitation was considered moderate if there was a
broad proximal jet filling half the left atrium or attenuation
of systolic flow from the pulmonary veins to the left atrium.
These criteria, with the addition of systolic flow reversal in
the pulmonary veins, were required for the diagnosis of
severe MR. Aortic regurgitation was considered to be
moderate if the diameter of the regurgitant jet was .20 to
30% of the diameter of the left ventricular outflow tract, in
association with diastolic flow reversal in the proximal
thoracic descending aorta. In addition to these criteria,
diastolic flow reversal in the abdominal descending aorta
was required for the diagnosis of severe AR (9–13).
Assessment of LV mechanics. The indirect arterial pulse
trace and the endocardial borders of the septum and the
endocardial and epicardial borders of the LV posterior wall
were digitized from the M-mode echocardiogram using
customized software and previously described methodology
(14,15). End-systole was defined as the time of aortic valve
closure and end-diastole as the time of maximum LV
chamber dimension. Left ventricle shortening fraction (SF)
and the rate-adjusted mean velocity of circumferential fiber
shortening (VCFC) were calculated using standard formu-
lae. The LV end-diastolic wall thickness:chamber dimen-
sion ratio (EDh/D) was calculated by dividing the end-
diastolic posterior wall thickness by the end-diastolic
dimension, and the end-diastolic short axis:long axis ratio
was calculated as the short axis end-diastolic dimension
divided by the long axis end-diastolic dimension. Circum-
ferential wall stress was estimated at end-systole (ESSc)
using Mirsky’s formula:
ESSc 5
(1.35)(Pes)(Des)(Les)
2(hes)[Les 1 (0.55Des) 1 (1.1hes)]
where P is pressure in mm Hg, D is dimension cm, L is
length in cm, and h is the posterior wall thickness in cm
(16).
Calculation of z-scores relative to the normal population.
The relationship between the end-diastolic dimension and
body surface area was determined in the normal population
(Table 1). Body surface area-corrected z-scores were then
calculated so that the z-score, or normal deviate, represented
Abbreviations and Acronyms
ARF 5 acute rheumatic fever
AR 5 aortic regurgitation
EDh/D 5 End-diastolic wall thickness:chamber
dimension ratio
ESSc 5 circumferential end-systolic wall stress
LV 5 left ventricle
MR 5 mitral regurgitation
SF 5 shortening fraction
SVI 5 stress-velocity index
VCFC 5 rate-corrected mean velocity of
circumferential fiber shortening
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the number of standard deviations from the normal popu-
lation mean value. In the normal population there was no
relationship between age, body surface area or gender and
function indexes (SF and VCFC), ESSc, EDh/D or the
short axis:long axis ratio. Z-scores for these variables were
derived relative to the mean value and standard deviation of
the normal population (Table 1).
The stress-velocity index (SVI) was calculated as the relation
between VCFC and end-systolic wall stress and expressed as a
z-score relative to the normal relationship. For example, an
SVI ,22 indicates a VCFC ,2SD below the normal popu-
lation mean for a given level of ESSc. To account for patients
with elevated ESSc, the SVI was obtained by extrapolation of
the normal VCFC to ESSc relationship using diverging con-
fidence intervals. As ESSc is an index of afterload that relates
closely to fiber shortening (17) and VCFC is relatively inde-
pendent of changes in preload (18,19), the SVI is an afterload-
adjusted, preload-independent index of contractility (20).
Statistical analysis. Differences between the normal pop-
ulation and groups I and II were examined by one-way
analysis of variance, while differences between groups I and
II over time were analyzed with repeated measures analysis
of variance. The Newman-Keuls multiple comparison test
was used to determine individual group differences. Other
intergroup differences were analyzed by t-test. Categorical
variables were compared by chi-square test and Fisher exact
test. Scatter diagrams and then univariate and multivariate
linear regression were used to identify factors influencing
the SVI during ARF and at follow-up. A p value of ,0.05
was considered to be statistically significant.
The study was approved by the hospital ethics committee,
and informed consent was obtained from all normal subjects
and from patients with ARF in whom echocardiography
was not considered part of routine clinical follow-up.
RESULTS
During ARF. Group I patients had a mild increase in LV
end-diastolic dimension compared with normal patients,
with no difference in the EDh/D (Table 2). The end-
diastolic short axis:long axis ratio was increased indicating
spherical remodeling. These changes were confined to the
subgroup of group I with mild regurgitation; all the above
indexes were normal in those with no valve regurgitation.
Afterload (ESSc), function (SF and VCFC) and contractil-
ity (SVI) were normal (Table 2).
Left ventricle mechanics in group II patients were char-
acterized by a marked increase in the end-diastolic dimen-
sion and reduction in the EDh/D (Table 2). In addition,
ventricular shape was abnormal with a marked increase in
the short axis:long axis ratio. Afterload (ESSc) was elevated,
while SF and VCFC were reduced. The degree of reduction
in SF was less than that of VCFC (p 5 0.047), suggesting
preload augmentation of fiber shortening. Because the
Table 1. Echocardiographic Variables in the Normal Population
Regression Equation or Mean SEE or SD
EDD (cm) EDD 5 3.88 3 BSA0.409 0.325
EDh/D 0.1606 0.0243
ED SA/LA 0.61 0.05
SF (%) 33.3 2.74
VCFC (circ/sec) 1.02 0.084
ESSc (g/cm2) 93.1 13.3
SVI VCFc 5 20.002 3 ESSc 1 1.21 0.0804
BSA 5 body surface area; EDD 5 End-diastolic dimension; EDh/D 5 end-diastolic
wall thickness:chamber dimension ratio; ED SA/LA 5 end-diastolic short axis:long
axis ratio; ESSc 5 circumferential end-systolic wall stress; SD 5 standard deviation;
SEE 5 standard error of the estimate; SF 5 shortening fraction; SVI 5 stress-
velocity index; VCFc 5 rate-corrected velocity of circumferential fiber shortening.
Table 2. LV Mechanics During and After ARF
Group
During ARF After ARF Repeated Measures ANOVA
Mean 6 1 SD vs. Normal Mean 6 1 SD vs. Normal Group Time Interaction
EDDz I 0.6 6 0.9 1 0.3 6 1.0 NS ,0.001 0.02
NS
II 3.6 6 1.8† 11 2.0 6 1.9†§ 11
EDh/Dz I 0.1 6 1.0 NS 0.1 6 0.9 NS 0.003 NS
NS
II 21.0 6 1.0† 22 20.2 6 1.2‡ NS
ED SA/LAz I 0.8 6 1.3 11 0.1 6 1.0 NS 0.002 0.05
NS
II 2.2 6 1.6† 11 1.4 6 1.9† 11
SFz I 0.3 6 1.5 NS 0.1 6 1.2 NS 0.007 NS
NS
II 20.8 6 1.4* 22 20.5 6 1.1 NS
VCFcz I 0.3 6 1.3 NS 0.1 6 1.1 NS ,0.001 NS
NS
II 21.3 6 1.5† 22 21.0 6 1.0† 22
ESScz I 20.3 6 1.3 NS 20.2 6 1.2 NS 0.03 0.02
0.01
II 1.4 6 1.8† 11 20.4 6 1.1§ NS
SVI I 0.2 6 1.3 NS 0.1 6 1.1 NS ,0.001 NS
NS
II 20.9 6 1.4† 22 21.2 6 1.0† 22
*p , 0.05 group I vs. group II; †p , 0.01 group I vs. group II; ‡p , 0.05 during ARF vs. and after ARF; §p , 0.01 during ARF vs. after ARF;2 or1 p , 0.05 vs. normal
population; 22 or 11 p , 0.01 vs. normal population.
ANOVA 5 analysis of variance; ARF 5 acute rheumatic fever; NS 5 not significant (p . 0.05); vs. normal 5 p value compared with normal population; z 5 z-score. Other
abbreviations as in Table 1.
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reduction in VCFC was greater than could be attributed to
the increase in afterload, the SVI was depressed, indicating
impaired LV myocardial contractility (Table 2, Fig. 1).
Predictors of LV contractility during ARF. There was a
significant relationship between the SVI and the degree of
regurgitation (Table 2). Furthermore, depressed contractility
(SVI ,22) was a more frequent finding in patients with
moderate or severe valve regurgitation, being detected in 2 of
33 (6%) group I patients compared with 6 of 22 (27%) group
II patients (p 5 0.049). Although group II patients with AR
had a similar degree of ventricular dilatation as those with
isolated MR (end-diastolic dimension z-score 3.4 6 1.6,
n 5 12 [AR] vs. 3.7 6 2.0, n 5 10 [MR]), the reduction in
the SVI was largely confined to those with significant AR
(Fig. 2). There was no relationship between the SVI and the
time between hospital admission and the initial echocardio-
graphic examination, the erythrocyte sedimentation rate,
the age at presentation, gender, or initial versus recurrent
episode by univariate or multivariate analysis.
After ARF. In group I patients all parameters of ventricular
size, function and contractility were normal at follow-up
examination (Table 2), and there was no significant differ-
ence between the initial and follow-up examinations for any
of these variables.
In group II patients there was a tendency for valve
regurgitation to improve at follow-up. Of the 14 patients
with follow-up data treated nonsurgically, regurgitation
improved by at least one grade in 6 (43%). Regurgitation
was mild or less in four of the five surgical patients with
follow-up data, while it decreased from severe to moderate
in one child who underwent mitral valve repair. Hence, 11
patients (58%) demonstrated some degree of improvement
in the severity of valve regurgitation, so that 9 had no or
mild regurgitation; 5 had moderate regurgitation, and 5 had
severe regurgitation at the time of follow-up. Nevertheless,
group II patients exhibited persistent LV dilatation (Table
2), albeit to a lesser extent than during the initial examina-
tion. End-diastolic wall thickness:chamber dimension ratio
had normalized as had ESSc, the latter being significantly
lower compared with the initial examination. Although SF
had also normalized, VCFC remained depressed so that the
SVI was reduced, indicating a persistent impairment of LV
contractility (Table 2).
Predictors of LV myocardial contractility after ARF. As
was the case during ARF the degree of valve involvement at
presentation was an important predictor of the SVI at the
follow-up examination (Table 2). Furthermore, an abnor-
mal SVI (,22) was observed in no group I patient
compared with 5 of 19 (26.3%) group II patients (p 5 0.01).
Figure 1. Left ventricular end-systolic wall stress-velocity of shortening
relationships during acute rheumatic fever. The shaded area demarcated by
the solid line indicates the normal range (mean 6 2 standard deviations).
The dashed lines indicate extrapolation of the relationship to abnormal
levels of end-systolic wall stress. Group I 5 no or mild aortic or mitral
regurgitation; group II 5 moderate or severe aortic or mitral regurgitation
(see text for details). ESSc 5 circumferential end-systolic wall stress;
VCFC 5 rate corrected velocity of circumferential fiber shortening.
Figure 2. (A) Velocity of shortening-end-systolic wall stress relationship
by regurgitant valve during acute rheumatic fever in group II patients. The
shaded area indicates the normal range. (B) The stress-velocity relation-
ships for the same patient group derived from (A). Large symbols and
bars 5 mean 6 one standard deviation. p values are derived from
comparison with the normal population and between the two valve groups
using the Newman-Keuls multiple comparison test (see text for details).
AR 5 aortic regurgitation; ESSc 5 circumferential end-systolic wall stress;
MR 5 mitral regurgitation; VCFC 5 rate corrected velocity of circumfer-
ential fiber shortening.
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There was no significant relationship between the SVI and
age, gender, or the interval between the initial examination
and follow-up examination by univariate or multivariate
analysis.
Impact of surgery on LV contractility in those with
moderate or severe regurgitation. The five patients who
had valve replacement or repair had a lower end-diastolic
diameter at follow-up when compared with those who did
not undergo surgery (Table 3). Although the follow-up SVI
was not significantly different between the surgical and
nonsurgical groups, it had deteriorated significantly between
the initial and follow-up examination in the nonsurgical
group. In contrast it tended to improve in the surgical group
(Table 3). Thus, the change in SVI was different in the two
groups (change in SVI 20.7 6 1.2 [nonsurgical] vs. 1.3 6
1.3 [surgical], p 5 0.005). On further analysis of the
nonsurgical group, those whose regurgitation was un-
changed at follow-up had a significantly lower SVI when
compared with those with a spontaneous improvement in
the degree of regurgitation (21.9 6 0.3 vs. 20.8 6 0.6, p 5
0.03). Thus, the progressive contractile dysfunction in the
nonsurgical group was largely confined to those with per-
sistent significant valve regurgitation. It was not related to
the initial severity of the valve lesion (moderate vs. severe) or
the valve affected (aortic vs. mitral).
DISCUSSION
This study demonstrates that myocardial contractile func-
tion is closely related to the degree of valve regurgitation
during ARF. When regurgitation is mild, changes in LV
size and shape were minimal, and indexes of fiber shorten-
ing, afterload and contractile function were normal. At late
follow-up ventricular size, shape and function were normal.
In contrast, those with more severe valve lesions had
marked abnormalities of LV geometry and function. Left
ventricle dilation was accompanied by a reduction in the LV
wall thickness:chamber dimension ratio indicating a poorly
compensated volume load. Indexes of function (SF and
VCFC) were depressed, and both preload (as indicated by
the discrepancy between the SF and VCFC) and afterload
were increased. Importantly, when corrected for afterload,
the velocity of shortening remained depressed, indicating
impaired ventricular contractility. At follow-up group II
patients demonstrated a reduction in the severity of valve
regurgitation, a reduction in the degree of LV dilatation and
normalization of afterload. Nevertheless, both VCFC and
SVI remained depressed, indicating a persistent reduction in
myocardial contractility. Preload augmentation of ventricu-
lar function masked a significant impairment in the LV
contractile state, demonstrating the importance of account-
ing for loading conditions when assessing myocardial con-
tractility in this patient population.
A number of factors may detrimentally affect LV myo-
cardial contractility during ARF. These include primary
rheumatic myocardial involvement with myocyte damage
and fibrosis (21,22) and myocardial damage secondary to
sudden increases in ventricular volume and afterload asso-
ciated with the acute onset of MR or AR. Chronic volume
load associated with longstanding valve regurgitation may
also contribute (23–26), given that previous episodes of
rheumatic fever may be undiagnosed. In addition, primary
myocardial involvement, as evidenced by histological abnor-
malities of the myocardium, has been well documented
during ARF (21,22). Nevertheless, its impact on the con-
tractile state of the myocardium during the acute phase of
the illness and its long-term importance is poorly under-
stood and remains controversial (6,7,21). In this study
myocardial involvement appeared clinically unimportant in
those with little or no echocardiographic manifestation of
valvulitis, while the ventricular remodeling and contractile
dysfunction seen in those with more significant valve lesions
can be attributed to mechanical factors secondary to valve
regurgitation.
AR versus MR. During ARF depressed contractility was
largely confined to those patients with significant AR, either
as an isolated lesion or in combination with MR. This
disparity can be explained by differences in the pathophys-
iology of acute or subacute AR and MR. In animal models
acute MR is associated with normal or reduced wall stress.
Consequently the velocity of shortening often increases and
contractility is maintained (27,28). Over time a chronic
volume load will result in a progressive reduction in con-
tractile function as was seen at the follow-up examination in
this study. In contrast, the increased end-systolic pressure
and increased wall stress evident during acute AR is asso-
ciated with a reduction in the velocity of shortening (27,28).
Table 3. Group II Patients Treated With (n 5 5) and Without (n 5 14) Surgery
During ARF
Mean 6 1SD
After ARF
Mean 6 1SD
Repeated Measures ANOVA
Group Time Interaction
EDDz
No surgery 3.1 6 1.8 2.6 6 1.6
NS 0.003 0.013Surgery 4.5 6 1.6 0.2 6 0.8*‡
SVI
No surgery 20.7 6 1.4 21.4 6 1.0†
NS NS 0.007Surgery 22.0 6 1.2* 20.7 6 1.1
*p , 0.05 comparing no surgery vs. surgery; †p , 0.05 during ARF vs. after ARF; ‡p , 0.01 during ARF vs. after ARF.
Abbreviations as in Tables 1 and 2.
The analysis excludes three patients with no available follow-up data.
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Elevated wall stress increases myocardial oxygen demand
while tachycardia and diastolic hypotension compromise
oxygen delivery. This combination of events likely explains
the prevalence of contractile dysfunction for patients with
significant AR.
Surgical intervention. The number of patients treated
surgically was small, but the dependence of contractile
dysfunction on mechanical factors is further demonstrated
by the differences between the surgical and nonsurgical
groups at follow-up. Those who underwent valve surgery
had no further deterioration in contractility, while those
who did not demonstrated a progressive decline, particularly
if the degree of regurgitation remained significant. These
data are in concordance with those of Essop and coworkers
(7) who found a normal shortening fraction after valve
replacement surgery for patients with ARF.
In our experience, and in that of others (29), valve surgery
during ARF conveys a high likelihood of valve replacement.
Because of this we have restricted surgical intervention to
those with persistent heart failure despite bed rest and
medical treatment. However, the favorable influence of
valve surgery on the evolution of contractile dysfunction
suggests that a low or declining stress-velocity relationship
may also be an indication for surgical intervention. Such a
strategy appears appropriate given that myocardial contrac-
tile function is an important predictor of long-term outcome
for patients with valve regurgitation (23,30,31). Neverthe-
less, numbers in this study are small, and further investiga-
tion is needed to establish indications for surgery during
ARF.
Study limitations. Initial studies were undertaken during
ARF. In some instances this was after a period of hospitaliza-
tion at another institution, and the study was performed some
time into the acute illness. There was no association between
any of the measured echocardiographic parameters and time
from admission to a hospital, indicating that this factor is
unlikely to have influenced the findings of this study.
Similarly, the diagnosis of recurrent rheumatic fever may be
difficult to make with certainty. We have combined patients
who had a known recurrence with those in whom a
recurrence was suspected by history; there may be others
who had previous, undiagnosed episodes of rheumatic fever.
Again, the lack of correlation between recurrence and
echocardiographic parameters suggests this factor is not an
important confounding variable.
Finally, the SVI was derived from comparison of the
relationship between ESSc and VCFC with that of the
normal population. Practical and ethical difficulties have
prevented us from obtaining normal data at elevated after-
load in this age group. At the initial examination a number
of group II patients had elevated end-systolic wall stress,
and the SVI for these patients was obtained by extrapolation
of the normal data. Confidence intervals for the wall
stress-velocity of shortening relationship may be less accu-
rate under these circumstances. Importantly, afterload was
elevated in only one patient at the follow-up examination.
Furthermore, there was no relationship between the change
in SVI and change in afterload, indicating that alterations in
the SVI were unlikely to be related to misrepresentation of
the stress-shortening relationship.
Conclusions. During ARF, LV contractile function is
closely related to the degree of valve regurgitation, and
contractile dysfunction is uncommon when there is no
significant valve lesion. The dependence of contractility on
the degree and type of regurgitation and on surgical inter-
vention suggests that mechanical factors—acute and chronic
volume and pressure loading—are the major contributors to
myocardial damage.
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